We determined ANGPTL-3 and ANGPTL-4 levels in five groups of clinical samples ranging from the acutely infected with almost no liver fibrosis to cirrhotic patients with HCC. This evidence concerns the gene ANGPTL3 and Hepatic fibrosis.